Source: Annual Congress 2008 - Respiratory structure and function



Rating:

Share or cite this content

Citations should be made in the following way:
T. Zhavoronok, E. Stepovaya, N. Ryazanceva, G. Petina, F. Tetenev, T. Ageeva, V. Ivanov, Y. Starikov, S. Mishustin (Tomsk, Russian Federation). Community-acquired pneumonia acute period: neutrophil redox-potential and protein oxidative modification process. Eur Respir J 2008; 32: Suppl. 52, 969

Member's Comments

No comment yet.

Related content which might interest you: Estimation of inflammatory process activity in community-acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Enhanced PMN response in chronic bronchitis and community-acquired pneumonia Source: Eur Respir J 2004; 24 : 772-778 Year: 2004 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis Source: Eur Respir Rev, 29 (157) 200240; 10.1183/16000617.0240-2020 Year: 2020 Corticosteroids in severe pneumonia Source: Eur Respir J 2008; 32: 259-264 Year: 2008 Community-acquired pneumonia Source: Respipedia Article Year: 2017 Extracellular inhibition of neutrophil elastase activity reduces acute lung injury and bacterial count in streptococcus pneumonia infected hamsters Source: Eur Respir J 2007; 30: Suppl. 51, 51s Year: 2007 Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005 Community-acquired pneumonia: impact of COPD Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 The effect of NO synthesis modulators on calcium accumulation and neutrophil apoptosis during the community-acquired pneumonia Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Community-acquired pneumonia: treatment failure and complications Source: ERS Course 2018 - Respiratory Infections Year: 2018 Macrophage activation in exacerbated COPD with and without community-acquired pneumonia Source: Eur Respir J 2010; 36: 285 Year: 2010 Dynamic changes of markers of endothelial function, hemostasis, fibrinolysis and inflammation in hospitalized patients with community-acquired pneumonia Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 Neutrophil extracellular traps levels are associated to severity and complications in community-acquired pneumonia Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Erythrocyte and blood plasma antioxidant system status during the community-acquired pneumonia acute period Source: Eur Respir J 2006; 28: Suppl. 50, 1s Year: 2006 Community-acquired pneumonia: severity and antibiotic treatments Source: ERS Course 2018 - Respiratory Infections Year: 2018 Community-acquired pneumonia in outpatients: aetiology and outcomes}, Source: Eur Respir J 2012; 40: 931-938 Year: 2012 CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013